Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Getting away from it all in Capri: the 2008 EMBO workshop on NF-kappaB.

Gilmore TD, Perkins ND, Franzoso G.

Cell Death Differ. 2009 Apr;16(4):651-4. doi: 10.1038/cdd.2009.3. No abstract available.

2.

NF-kappa B signaling and carcinogenesis.

Okamoto T, Sanda T, Asamitsu K.

Curr Pharm Des. 2007;13(5):447-62. Review.

PMID:
17348842
3.

IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis.

Bollrath J, Greten FR.

EMBO Rep. 2009 Dec;10(12):1314-9. doi: 10.1038/embor.2009.243. Review.

4.

Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.

Wong ET, Tergaonkar V.

Clin Sci (Lond). 2009 Mar;116(6):451-65. doi: 10.1042/CS20080502. Review.

PMID:
19200055
5.

NF-kappaB as a potential molecular target for cancer therapy.

Lee CH, Jeon YT, Kim SH, Song YS.

Biofactors. 2007;29(1):19-35. Review.

PMID:
17611291
6.

Crosstalk in NF-κB signaling pathways.

Oeckinghaus A, Hayden MS, Ghosh S.

Nat Immunol. 2011 Jul 19;12(8):695-708. doi: 10.1038/ni.2065. Review.

PMID:
21772278
7.

NF-kappa B as a therapeutic target in neurodegenerative diseases.

Camandola S, Mattson MP.

Expert Opin Ther Targets. 2007 Feb;11(2):123-32. Review.

PMID:
17227229
8.

Role of the NF-kappaB pathway in the pathogenesis of human disease states.

Yamamoto Y, Gaynor RB.

Curr Mol Med. 2001 Jul;1(3):287-96. Review.

PMID:
11899077
9.

NF-κB in cellular senescence and cancer treatment.

Jing H, Lee S.

Mol Cells. 2014 Mar;37(3):189-95. doi: 10.14348/molcells.2014.2353. Review.

10.

Genetic dissection of antigen receptor induced-NF-kappaB activation.

Li ZW, Rickert RC, Karin M.

Mol Immunol. 2004 Jul;41(6-7):701-14. Review.

PMID:
15220005
12.

NF-κB and the link between inflammation and cancer.

DiDonato JA, Mercurio F, Karin M.

Immunol Rev. 2012 Mar;246(1):379-400. doi: 10.1111/j.1600-065X.2012.01099.x. Review.

PMID:
22435567
13.

The Re1/NF-kappa B/I kappa B signal transduction pathway and cancer.

Gilmore TD.

Cancer Treat Res. 2003;115:241-65. Review. No abstract available.

PMID:
12613200
14.

NF-kappa B as a target for cancer therapy.

Melisi D, Chiao PJ.

Expert Opin Ther Targets. 2007 Feb;11(2):133-44. Review.

PMID:
17227230
15.

The role of NF-kappaB in lymphoid malignancies.

Packham G.

Br J Haematol. 2008 Oct;143(1):3-15. doi: 10.1111/j.1365-2141.2008.07284.x. Review.

PMID:
18573107
16.

Introduction to NF-kappaB: players, pathways, perspectives.

Gilmore TD.

Oncogene. 2006 Oct 30;25(51):6680-4. Review.

PMID:
17072321
17.

Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis.

González-Ramos R, Van Langendonckt A, Defrère S, Lousse JC, Colette S, Devoto L, Donnez J.

Fertil Steril. 2010 Nov;94(6):1985-94. doi: 10.1016/j.fertnstert.2010.01.013. Review.

PMID:
20188363
18.

Transcriptional regulation via the NF-kappaB signaling module.

Hoffmann A, Natoli G, Ghosh G.

Oncogene. 2006 Oct 30;25(51):6706-16. Review.

PMID:
17072323
19.

NF-κB signaling in B-1 cell development.

Pedersen GK, Ádori M, Karlsson Hedestam GB.

Ann N Y Acad Sci. 2015 Dec;1362:39-47. doi: 10.1111/nyas.12800. Review.

PMID:
26096766
20.

The role of nuclear factor kappa B in human labour.

Lindström TM, Bennett PR.

Reproduction. 2005 Nov;130(5):569-81. Review.

Items per page

Supplemental Content

Support Center